LBT Innovations Ltd
ASX:LBT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
LBT Innovations Ltd
ASX:LBT
|
AU |
|
L
|
LIX Detergent JSC
VN:LIX
|
VN |
|
M
|
MoneyGram International Inc
F:9M1N
|
US |
|
Monopar Therapeutics Inc
NASDAQ:MNPR
|
US |
|
INOX Leisure Ltd
NSE:INOXLEISUR
|
IN |
|
A
|
Arizona Sonoran Copper Company Inc
TSX:ASCU
|
CA |
|
Hubei Guangji Pharmaceutical Co Ltd
SZSE:000952
|
CN |
|
Grupo Pochteca SAB de CV
BMV:POCHTECB
|
MX |
|
A
|
Arem Pacific Corp
OTC:ARPC
|
AU |
|
Aroa Biosurgery Ltd
ASX:ARX
|
NZ |
|
G
|
Garda Diversified Property Fund
ASX:GDF
|
AU |
|
Benchmark Electronics Inc
NYSE:BHE
|
US |
|
A
|
Anhui Wanwei Updated High-tech Material Industry Co Ltd
SSE:600063
|
CN |
|
W
|
Waterdrop Inc
NYSE:WDH
|
CN |
|
Atlantic American Corp
NASDAQ:AAME
|
US |
|
T
|
TeamViewer SE
F:TMV1
|
DE |
|
E
|
E-Data Teknoloji Pazarlama AS
IST:EDATA.E
|
TR |
|
Eolus Vind AB (publ)
STO:EOLU B
|
SE |
|
S
|
SRIVARU Holding Ltd
NASDAQ:SVMH
|
KY |
|
TCI Express Ltd
NSE:TCIEXP
|
IN |
|
TTK Prestige Ltd
NSE:TTKPRESTIG
|
IN |
|
Lazydays Holdings Inc
F:5ZL
|
US |
LBT Innovations Ltd
LBT Innovations Ltd. is an Australian developer of clinical and diagnostic technology, which has emerged as a groundbreaking designer of advanced automated solutions for the preparation and analysis of microbiology culture specimens, with significant benefits for busy clinical laboratories. The company is headquartered in Adelaide, South Australia. The company went IPO on 2006-07-31. The firm is engaged in researching, developing and commercializing technologies for the healthcare and laboratory supply markets. The firm's product pipeline includes The Automated Plate Assessment System for antimicrobial resistance (APAS-AMR), WoundVue, Biofilm, Automated Gram Stain Assessment and MicroStreak. The firm's Automated Plate Assessment System (APAS) Independence is a platform technology that automates culture-plate screening and interpretation. APAS Independence screens, interprets, and sorts these plates, overcoming the bottleneck in lab workflows and freeing up microbiologist's time. Its APAS Analysis Modules are the intelligent image analysis software that works together with the APAS Independence to enable the screening of microbiology culture plates.
LBT Innovations Ltd. is an Australian developer of clinical and diagnostic technology, which has emerged as a groundbreaking designer of advanced automated solutions for the preparation and analysis of microbiology culture specimens, with significant benefits for busy clinical laboratories. The company is headquartered in Adelaide, South Australia. The company went IPO on 2006-07-31. The firm is engaged in researching, developing and commercializing technologies for the healthcare and laboratory supply markets. The firm's product pipeline includes The Automated Plate Assessment System for antimicrobial resistance (APAS-AMR), WoundVue, Biofilm, Automated Gram Stain Assessment and MicroStreak. The firm's Automated Plate Assessment System (APAS) Independence is a platform technology that automates culture-plate screening and interpretation. APAS Independence screens, interprets, and sorts these plates, overcoming the bottleneck in lab workflows and freeing up microbiologist's time. Its APAS Analysis Modules are the intelligent image analysis software that works together with the APAS Independence to enable the screening of microbiology culture plates.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
